Retour
17
Fourchette du Jour
34,01 €
50,37 €
Fourchette 52 Semaines
28,66 €
117,33 €
Volume
11 718 296
Moyenne 50J / 200J
37,45 €
/
64,86 €
Clôture Précédente
33,82 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 43,2 | 0,2 |
| P/B | 6,7 | 3,0 |
| ROE % | 15,0 | 3,6 |
| Net Margin % | 13,1 | 3,8 |
| Rev Growth 5Y % | 20,1 | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
68,40 €
+69.0%
Low: 30,00 €
High: 100,00 €
P/E Prévisionnel
113,27
BPA Prévisionnel
0,36 €
Croissance BPA (est.)
+0,0%
CA Est.
884,47M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
8,40 €
7,62 € – 9,46 €
|
2,56B | 1 |
| FY2029 |
6,13 €
5,56 € – 6,90 €
|
2,12B | 1 |
| FY2028 |
2,89 €
2,15 € – 4,09 €
|
1,53B | 3 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-24 | 0,33 € | 0,20 € | -39,4% |
| 2025-11-04 | 0,18 € | 0,16 € | -11,1% |
| 2025-07-31 | 0,23 € | 0,29 € | +26,1% |
| 2025-05-05 | 0,17 € | 0,17 € | 0,0% |
| 2025-02-26 | 0,37 € | 0,26 € | -29,7% |
| 2024-10-30 | 0,28 € | 0,41 € | +46,4% |
| 2024-07-29 | 0,23 € | 0,32 € | +39,1% |
| 2024-05-01 | 0,22 € | 0,25 € | +13,6% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue grew 20,10% annually over 5 years — strong growth
Earnings declined -28,68% over the past year
ROE of 15,01% — decent returns on equity
Debt/Equity of 0,01 — conservative balance sheet
Generating 141,79M in free cash flow
P/E of 43,20 — premium valuation
Croissance
Revenue Growth (5Y)
20,10%
Revenue (1Y)12,79%
Earnings (1Y)-28,68%
FCF Growth (3Y)5,70%
Qualité
Return on Equity
15,01%
ROIC5,14%
Net Margin13,09%
Op. Margin5,88%
Sécurité
Debt / Equity
0,01
Current Ratio2,92
Interest Coverage0,00
Valorisation
P/E Ratio
43,20
Forward P/E113,27
P/B Ratio6,65
EV/EBITDA93,55
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 12,79% | Revenue Growth (3Y) | 25,64% |
| Earnings Growth (1Y) | -28,68% | Earnings Growth (3Y) | -3,10% |
| Revenue Growth (5Y) | 20,10% | Earnings Growth (5Y) | -2,99% |
| Profitability | |||
| Revenue (TTM) | 761,41M | Net Income (TTM) | 99,65M |
| ROE | 15,01% | ROA | 11,91% |
| Gross Margin | 98,30% | Operating Margin | 5,88% |
| Net Margin | 13,09% | Free Cash Flow (TTM) | 141,79M |
| ROIC | 5,14% | FCF Growth (3Y) | 5,70% |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 2,92 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 43,20 | Forward P/E | 113,27 |
| P/B Ratio | 6,65 | P/S Ratio | 5,65 |
| PEG Ratio | -1,22 | Forward PEG | N/A |
| EV/EBITDA | 93,55 | Fwd EV/EBITDA | 20,56 |
| Forward P/S | 4,87 | Fwd Earnings Yield | 0,88% |
| FCF Yield | 3,29% | ||
| Market Cap | 4,30B | Enterprise Value | 4,19B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 761,41M | 675,04M | 482,38M | 401,86M | 365,98M |
| Net Income | 99,65M | 139,73M | 106,14M | 101,42M | 112,51M |
| EPS (Diluted) | 0,82 | 1,23 | 0,94 | 0,87 | 0,89 |
| Gross Profit | 748,43M | 664,16M | 475,89M | 396,47M | 360,70M |
| Operating Income | 44,80M | 136,95M | 107,28M | 112,63M | 124,48M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 836,65M | 840,55M | 621,52M | 583,43M | 423,76M |
| Total Liabilities | 188,85M | 160,96M | 114,81M | 81,59M | 47,95M |
| Shareholders' Equity | 647,81M | 679,59M | 506,71M | 501,84M | 375,81M |
| Total Debt | 6,11M | 6,94M | 151 000,0 | 1,14M | 526 000,0 |
| Cash & Equivalents | 120,50M | 127,67M | 135,55M | 66,33M | 77,62M |
| Current Assets | 485,46M | 471,60M | 458,64M | 499,25M | 266,46M |
| Current Liabilities | 166,09M | 140,77M | 104,51M | 72,49M | 47,54M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#1011 of 1049
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026